Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 5/2020

Ausgabe 5/2020

Inhaltsverzeichnis ( 19 Artikel )

09.03.2020 | Commentary | Ausgabe 5/2020 Open Access

Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies

Csaba Kerepesi, Tibor Bakacs, Ralph W. Moss, Shimon Slavin, Colin C. Anderson

06.02.2020 | Original Article | Ausgabe 5/2020 Open Access

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

Akinori Nukui, Takao Kamai, Kyoko Arai, Toshiki Kijima, Minoru Kobayashi, Takahiro Narimatsu, Tsunehito Kambara, Hideo Yuki, Hironori Betsunoh, Hideyuki Abe, Yoshitatsu Fukabori, Masahiro Yashi, Ken-Ichiro Yoshida

07.02.2020 | Original Article | Ausgabe 5/2020

The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients

Pierre Rosenbaum, Cécile Artaud, Sylvie Bay, Christelle Ganneau, Mario Campone, Suzette Delaloge, Carole Gourmelon, Delphine Loirat, Jacques Medioni, François Pein, Marie-Paule Sablin, Olivier Tredan, Andrea Varga, Claude Leclerc

08.02.2020 | Original Article | Ausgabe 5/2020 Open Access

Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients

Henna Kasanen, Micaela Hernberg, Siru Mäkelä, Oscar Brück, Susanna Juteau, Laura Kohtamäki, Mette Ilander, Satu Mustjoki, Anna Kreutzman

08.02.2020 | Original Article | Ausgabe 5/2020

Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization

Fransisca Leonard, Louis T. Curtis, Ahmed R. Hamed, Carolyn Zhang, Eric Chau, Devon Sieving, Biana Godin, Hermann B. Frieboes

11.02.2020 | Original Article | Ausgabe 5/2020

Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes

Kenichiro Yahiro, Yoshihiro Matsumoto, Hisakata Yamada, Makoto Endo, Nokitaka Setsu, Toshifumi Fujiwara, Makoto Nakagawa, Atsushi Kimura, Eijiro Shimada, Seiji Okada, Yoshinao Oda, Yasuharu Nakashima

12.02.2020 | Original Article | Ausgabe 5/2020 Open Access

Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients

Anne Fröhlich, Dennis Niebel, Simon Fietz, Eva Egger, Andrea Buchner, Judith Sirokay, Jennifer Landsberg

12.02.2020 | Original Article | Ausgabe 5/2020 Open Access

Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients

Daan P. Hurkmans, Merian E. Kuipers, Jasper Smit, Ronald van Marion, Ron H. J. Mathijssen, Piet E. Postmus, Pieter S. Hiemstra, Joachim G. J. V. Aerts, Jan H. von der Thüsen, Sjoerd H. van der Burg

12.02.2020 | Original Article | Ausgabe 5/2020 Open Access

Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation

Fei-fei Gu, Jing-jing Wu, Yang-yang Liu, Yue Hu, Jin-yan Liang, Kai Zhang, Ming Li, Yan Wang, Yong-an Zhang, Li Liu

13.02.2020 | Original Article | Ausgabe 5/2020

CD160 expression on CD8+ T cells is associated with active effector responses but limited activation potential in pancreatic cancer

Songyang Liu, Wei Zhang, Kai Liu, Yingchao Wang

13.02.2020 | Original Article | Ausgabe 5/2020

Co-expression of HLA-I loci improved prognostication in HER2+ breast cancers

Julia Y. Tsang, Chun-Sing Ho, Yun-Bi Ni, Yan Shao, Ivan K. Poon, Siu-Ki Chan, Sai-Yin Cheung, Ka-Ho Shea, Monalyn Marabi, Gary M. Tse

13.02.2020 | Original Article | Ausgabe 5/2020

Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia

Denise Risnik, Ana Colado, Enrique Podaza, María Belén Almejún, Esteban Enrique Elías, Raimundo Fernando Bezares, Horacio Fernández-Grecco, Noé Seija, Pablo Oppezzo, Mercedes Borge, Romina Gamberale, Mirta Giordano

14.02.2020 | Original Article | Ausgabe 5/2020

CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma

Qiu-Zhong Pan, Qing Liu, Yu-Qing Zhou, Jing-Jing Zhao, Qi-Jing Wang, Yong-Qiang Li, Yan Tang, Jia-Mei Gu, Jia He, Shi-Ping Chen, De-Sheng Weng, Jian-Chuan Xia

15.02.2020 | Original Article | Ausgabe 5/2020

LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development

Lining Zhou, Yu Tian, Fang Guo, Bin Yu, Jiali Li, Huaxi Xu, Zhaoliang Su

05.02.2020 | Clinical Trial Report | Ausgabe 5/2020 Open Access

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial

Masanori Noguchi, Gaku Arai, Shin Egawa, Chikara Ohyama, Seiji Naito, Kazumasa Matsumoto, Hirotsugu Uemura, Masayuki Nakagawa, Yasutomo Nasu, Masatoshi Eto, Shigetaka Suekane, Tetsuro Sasada, Shigeki Shichijo, Akira Yamada, Tatsuyuki Kakuma, Kyogo Itoh

01.05.2020 | Focussed Research Review | Ausgabe 5/2020 Open Access

Long-term surviving cancer patients as a source of therapeutic TCR

Else Marit Inderberg, Sébastien Wälchli

01.05.2020 | Focussed Research Review | Ausgabe 5/2020 Open Access

New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia

Stephanie Jordaens, Leah Cooksey, Laurie Freire Boullosa, Viggo Van Tendeloo, Evelien Smits, Ken I. Mills, Kim H. Orchard, Barbara-ann Guinn

04.03.2020 | Focussed Research Review | Ausgabe 5/2020

Current progress in NK cell biology and NK cell-based cancer immunotherapy

Raquel Tarazona, Nelson Lopez-Sejas, Beatriz Guerrero, Fakhri Hassouneh, Isabel Valhondo, Alejandra Pera, Beatriz Sanchez-Correa, Nieves Pastor, Esther Duran, Corona Alonso, Rafael Solana

05.02.2020 | Meeting Report | Ausgabe 5/2020 Open Access

“Tumor immunology meets oncology (TIMO) XV”, April 25th–27th 2019, Halle/Saale, Germany

André Steven, Chiara Massa, Barbara Seliger

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise